医学
电离辐射
放射治疗
放射性损伤
放射生物学
重症监护医学
医学物理学
外科
辐照
物理
核物理学
作者
Lianchang Liu,Zhenzhen Liang,Shumei Ma,Lan Li,Xiaodong Liu
标识
DOI:10.3892/mmr.2023.12953
摘要
A series of physiological and pathological changes occur after radiotherapy and accidental exposure to ionizing radiation (IR). These changes cause serious damage to human tissues and can lead to death. Radioprotective countermeasures are radioprotective agents that prevent and reduce IR injury or have therapeutic effects. Based on a good understanding of radiobiology, a number of protective agents have achieved positive results in early clinical trials. The present review grouped known radioprotective agents according to biochemical categories and potential clinical use, and reviewed radiation countermeasures, i.e., radioprotectors, radiation mitigators and radiotherapeutic agents, with an emphasis on their current status and research progress. The aim of the present review is to facilitate the selection and application of suitable radioprotectors for clinicians and researchers, to prevent or reduce IR injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI